查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1922991

全球患者體內給藥系統市場（按給藥方式、產品類型、技術、應用和最終用戶分類）預測（2026-2032 年）

Over Patient Delivery System Market by Delivery Mode, Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，海外病人輸送系統市場價值將達到 12.2 億美元，到 2026 年將成長到 13 億美元，到 2032 年將達到 20.1 億美元，年複合成長率為 7.36%。

主要市場統計數據
基準年 2025 12.2億美元
預計年份：2026年 13億美元
預測年份：2032年 20.1億美元
複合年成長率 (%) 7.36%

針對病患轉運系統的全面策略指南：重點關注營運影響、臨床整合需求以及相關人員的實用決策標準

本執行摘要為現代患者照護服務系統提供策略指南，整合了影響臨床實施和採購決策的營運、技術和監管因素。它闡述了醫院管理者、醫療設備製造商、支付方和創新團隊在評估影響病人安全、護理效率和護理連續性的設備和專案時必須應對的關鍵挑戰。它重點闡述了不斷變化的護理環境、患者期望和設備互通性如何相互交織，從而重新定義整個護理過程中的價值提案。

技術、臨床和監管方面的變革正在重新定義患者照護服務體系，並提高了誠信、安全和真實世界證據的標準。

以病患為導向的醫療設備系統格局正經歷根本性的變革，其驅動力來自於科技的融合、醫療服務模式的轉變以及日益成長的安全期望。小型化、感測器整合和互聯互通技術的進步，催生了新一代醫療設備，它們不再局限於單一功能硬體，而是成為可互通臨床生態系統的組成部分。隨著醫療系統尋求能夠減輕醫護人員負擔、同時提高劑量、依從性和不利事件檢測數據準確性的醫療設備，這種變革正在影響採購重點。

2025 年美國關稅的累積影響將改變病患輸送系統的採購、設計重點和總成本考量。

2025年美國關稅的累積影響已對整個醫療服務供應鏈的營運和策略層面產生了顯著影響。關稅措施提高了某些進口零件和成品的本地到貨成本，迫使製造商和醫療系統重新評估其籌資策略、零件替代方案和庫存管理實踐。為此，採購部門正在加快供應商多元化進程，並加強合約談判，以在確保產品品質和合規性的同時降低風險。

深入了解給藥方式、產品類型、終端用戶環境、核心技術和臨床應用領域，以指導策略性產品和商業性選擇。

深入的市場細分揭示了臨床需求、使用者行為和技術之間的交集，從而在給藥方式、產品類型、最終用戶、技術和應用方面創造差異化價值。基於給藥方式，市場研究框架將系統分為自動化系統和手動系統。自動化解決方案進一步細分為大劑量投藥、連續式和間歇式給藥模式，而手動方案則以重力供液和擠壓式給藥為特徵。這些區分至關重要，因為自動化方案往往側重於封閉回路型控制、持續給藥和資料收集，而手動方案由於其簡便性和低維護成本，在資源匱乏的環境或需要快速回應的情況下仍然被廣泛採用。

區域採用模式和策略意義（美洲、歐洲、中東和非洲、亞太地區）正在影響商業化和產品組合決策。

區域趨勢影響著病患服務體系的採用管道、監管預期和供應鏈配置。領導者必須解讀區域訊號，並調整產品設計和打入市場策略。在美洲，醫療系統正增加對數位整合和上市後證據收集的投資，因此越來越傾向於選擇具備連接性、數據分析和清晰臨床性能指標的設備。人口結構變化和成本控制壓力也推動了該地區對支持門診和居家護理解決方案的興趣。

醫療設備製造商與技術專家之間的競爭與合作趨勢凸顯了策略性收購對互聯互通、卓越服務和差異化發展的影響。

領先的醫療設備製造商和技術提供者之間的競爭動態表明，他們在連接性、以用戶為中心的設計和循證醫學方面的優先事項趨於一致。擁有強大工程能力和完善售後服務的公司正贏得大型醫療系統採購部門的更多信任，這些部門將可維護性和供應商應對力視為設備整體性能的關鍵因素。此外，那些早期投資於安全連接和雲端分析的製造商，在展示設備長期性能和臨床醫生日益關注的依從性指標方面，也擁有競爭優勢。

針對製造商和醫療保健系統，提出以互通性、人體工學、消毒通訊協定和供應鏈彈性為重點的具體策略建議。

產業領導者應優先考慮互通性和供應鏈韌性，將其視為保持競爭優勢和臨床可靠性的當務之急。在設備架構中建立標準化的連接和開放API有助於與電子健康記錄（EHR）和遠端監測平台整合，最終促進臨床醫生採用並隨著時間的推移收集更多證據。除了技術整合之外，重點投資於人體工學測試和簡化使用者介面，將減輕培訓負擔，並降低非專業環境下使用者出錯的風險。

採用透明的多方法調查方法，結合專家訪談、設備技術評估和工作流程分析，以獲得可操作的營運洞察。

我們的研究途徑結合了定性專家訪談、設備層面的技術評估和跨職能工作流程分析，以三角驗證的方式深入了解技術性能和應用障礙。主要研究包括與臨床醫生、生物醫學工程師、採購人員和受過培訓的看護者進行結構化討論，以發現操作挑戰並檢驗設備在實際臨床場景下的可用性。此外，我們還對設備規格、滅菌要求和材料相容性進行了技術審查，以評估其對再處理和生命週期管理的影響。

摘要強調，高度互通性和人性化的交付系統對於實現臨床價值至關重要，而支持性證據和供應鏈韌性也至關重要。

總之，病患輸送系統融合了設備工程、臨床工作流程設計和醫療系統運作策略。智慧技術的整合、不斷變化的醫療環境以及日益嚴格的監管要求，正在重新定義採購者最為重視的屬性：互聯性、易用性、清晰的再處理流程以及可驗證的臨床療效。那些能夠將產品設計與實際臨床工作流程相契合、建立穩健的供應鏈並以上市後證據支持其主張的機構，將更有利於在各種醫療環境中實現持續推廣應用。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依給藥方式分類的過量病患給藥系統市場

  • 自動的
    • Bolus
    • 執著的
    • 間歇性
  • 手動的
    • 重力
    • 推

9. 依產品類型分類的超負荷病人輸送系統市場

  • 一次性
    • 塑膠
    • 矽
  • 可重複使用的
    • 高壓釜
    • 不可高壓釜

第10章 按技術分類的超患者輸送系統市場

  • 貼片幫浦
    • 免洗片
    • 可重複使用的補丁
  • 管子
    • PVC
    • 矽
  • 穿戴式裝置
    • 非智慧型穿戴裝置
    • 智慧型穿戴裝置

第11章 按應用分類的過量患者輸送系統市場

  • 麻醉
  • 點滴
  • 疼痛管理

第12章 依最終用戶分類的超額病人輸送系統市場

  • 診所
  • 居家照護
    • 患者自我給藥
    • 護理機構
  • 醫院
    • 緊急狀況
    • 普通病房
    • 加護病房

第13章 區域性病患配送系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 按組別分類的超重患者輸送系統市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國超額病患輸送系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國超重病人運輸系統市場

第17章：中國超重病患交付系統市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acteon Group
  • Anthos srl
  • Being Foshan Medical Equipment Co., Ltd.
  • Chirana Holding as
  • Cingolani Srl
  • Confident Dental Equipment Pvt. Ltd.
  • Dentsply Sirona Inc.
  • Diplomat Dental sro
  • Flight Dental Systems
  • Forest Dental Products, Inc.
  • Gnatus International Ltda.
  • Hican SA
  • KaVo Dental GmbH
  • Marus Dental International
  • Mestra Talleres SL
  • Midmark Corporation
  • Planmeca Oy
  • Ritter Concept GmbH
  • Stern Weber srl
  • Takara Belmont Corporation
  • United Medical Equipment Co., Ltd.
  • Yoshida Dental Mfg. Co., Ltd.
Product Code: MRR-867BED9A9EA9

The Over Patient Delivery System Market was valued at USD 1.22 billion in 2025 and is projected to grow to USD 1.30 billion in 2026, with a CAGR of 7.36%, reaching USD 2.01 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.22 billion
Estimated Year [2026] USD 1.30 billion
Forecast Year [2032] USD 2.01 billion
CAGR (%) 7.36%

A comprehensive strategic orientation to patient delivery systems highlighting operational impacts, clinical integration needs, and practical decision criteria for stakeholders

This executive summary provides a strategic orientation to contemporary patient delivery systems, synthesizing the operational, technological, and regulatory factors shaping clinical adoption and procurement decisions. It frames the critical questions that hospital administrators, device manufacturers, payers, and innovation teams must address when evaluating devices and programs that influence patient safety, care efficiency, and the continuity of therapy. The narrative emphasizes how changes in care settings, patient expectations, and device interoperability are intersecting to redefine value propositions across the care continuum.

The introduction focuses on the urgent operational pressures and strategic opportunities that characterize the current landscape. As health systems prioritize capacity optimization and whole-person care, the functional performance of delivery systems-including reliability, ease of use, and integration with digital health platforms-has emerged as a decisive factor in clinical selection and training investments. Consequently, leaders must evaluate delivery technologies not only on device-level specifications but also on lifecycle considerations such as sterilization protocols, compatibility with electronic health records, and the degree to which devices support decentralized care models.

Beyond procurement and clinical choice, the introduction also outlines methodological boundaries for the report and what readers should expect in subsequent sections. It clarifies that the emphasis is on operational impact, clinical workflow integration, and technology-driven enhancements rather than on financial forecasting, thereby equipping executives with practical insights for near- and mid-term strategic planning. The summary establishes a common framework for interpreting the more detailed analyses that follow and highlights the importance of cross-functional alignment among clinical, supply chain, and digital teams when implementing new delivery-system solutions.

Transformative technological, clinical, and regulatory shifts are redefining patient delivery systems and raising the bar for integration, safety, and real-world evidence

The patient delivery system landscape is undergoing foundational shifts driven by technology convergence, changing care delivery models, and elevated safety expectations. Advances in miniaturization, sensor integration, and connectivity have enabled a new generation of devices that move beyond single-function hardware to become nodes in an interoperable clinical ecosystem. This evolution is influencing procurement priorities as health systems seek devices that reduce clinician burden while increasing data fidelity for dosing, adherence, and adverse event detection.

Concurrently, care is migrating across traditional institutional boundaries. More therapies once confined to inpatient wards are being delivered in ambulatory clinics and in patients' homes, requiring devices designed for non-specialist use and for environments that lack centralized sterilization and asset management resources. These shifts are accelerating demand for designs that prioritize intuitive operation, simplified maintenance, and clear custodial responsibilities, as well as for training programs that can be scaled for care teams and patient caregivers alike.

Regulatory rigor and reimbursement dynamics are also reshaping device development pathways. Regulators are placing greater emphasis on risk-based approaches, human factors engineering, and post-market surveillance data. Payers and providers, in turn, are examining how device-related outcomes contribute to value-based care metrics such as readmissions, adverse events, and therapy adherence. As a result, manufacturers are increasingly required to demonstrate real-world performance and to provide evidence of how their systems affect clinical workflows and downstream resource utilization.

Finally, the rise of smart wearables and edge-computing capabilities is expanding the role of delivery systems from passive conduits to active caregivers that can adapt dosing or notify clinicians based on sensed physiologic changes. This transition amplifies both opportunity and complexity: device software, cybersecurity, and data governance become central to product differentiation and to the trust clinicians place in these technologies. Taken together, these transformative shifts are setting a higher bar for design, clinician training, and cross-stakeholder collaboration.

How the cumulative effects of United States tariff measures in 2025 are reshaping sourcing, design priorities, and total cost considerations for patient delivery systems

The cumulative impact of United States tariffs implemented in 2025 has introduced distinct operational and strategic consequences across the supply chain for patient delivery systems. Tariff policies have increased landed costs for specific imported components and finished devices, prompting manufacturers and health systems to re-evaluate sourcing strategies, component substitution, and inventory practices. In response, procurement teams have accelerated supplier diversification and intensified contract negotiations to mitigate exposure while maintaining product quality and regulatory consistency.

Manufacturers that rely on globalized production footprints have confronted the need to reassess their manufacturing network resiliency. Some have begun selective nearshoring of assembly or critical subassembly operations to stabilize input costs and reduce lead-time variability. This realignment has required investments in local compliance, workforce training, and quality infrastructure, and has sometimes lengthened product development timelines due to the need to qualify alternative suppliers under medical device regulatory frameworks.

The tariff environment has also intensified interest in design choices that reduce dependency on tariffed inputs. For instance, product engineering teams are prioritizing material substitutions, greater modularity, and enhanced compatibility with domestically sourced tubing, connectors, and sensor modules. In parallel, supply chain teams are placing a renewed emphasis on transparency, mapping multi-tier suppliers, and stress-testing alternative logistical routes to anticipate disruption.

For health system purchasers, the tariff-driven cost inflation has sharpened scrutiny of total cost of ownership and device lifecycle costs, rather than upfront price alone. Decisions increasingly hinge on comparative durability, ease of sterilization, and serviceability. Importantly, the tariff environment has catalyzed closer collaboration between clinical purchasers and engineering teams to ensure that procurement choices do not inadvertently compromise clinical performance or patient safety. Overall, tariffs have acted as a catalyst for structural changes in sourcing, product design, and procurement governance that will persist beyond immediate policy cycles.

Deep segmentation-driven insights across delivery mode, product type, end-user environments, core technologies, and clinical applications to guide strategic product and commercial choices

Insightful segmentation reveals where clinical need, user behavior, and technology intersect to create differentiated value across delivery modes, product types, end users, technologies, and applications. Based on Delivery Mode, market study frameworks distinguish Automated systems from Manual systems; Automated solutions further categorize into Bolus, Continuous, and Intermittent modalities, while Manual options are characterized by Gravity and Push approaches. These distinctions matter because automated implementations tend to emphasize closed-loop control, consistent dosing, and data capture, whereas manual approaches remain prevalent in low-resource or rapid-response contexts due to their simplicity and low-maintenance profiles.

Based on Product Type, devices are considered across Disposable and Reusable classes; the Disposable class includes Plastic and Silicone variants, and the Reusable class includes Autoclavable and Nonautoclavable options. Disposable plastic and silicone designs are often optimized for single-patient use and infection control, delivering operational simplicity for settings with constrained sterilization workflows. Reusable autoclave-compatible devices appeal to systems focused on lifecycle cost management and robust sterilization protocols, while nonautoclavable reusables require clearly defined cleaning protocols and may serve specialized clinical niches.

Based on End User, segmentation includes Clinics, Home Care, and Hospitals; Home Care is further parsed into Patient Self-Administered and Skilled Nursing use cases, while Hospitals are further segmented into Emergency, General Ward, and ICU environments. Each end-user category imposes different design and support requirements: clinics require compact, portable systems that support throughput; home care demands intuitive interfaces and caregiver assistance features; hospitals prioritize rapid response capability, interoperability with clinical monitoring systems, and durability under frequent reprocessing. The ICU context, in particular, places a premium on integration with hemodynamic monitoring and alarm management systems.

Based on Technology, analysis differentiates Patch Pump, Tubing, and Wearable solutions; the Patch Pump category is subdivided into Disposable Patch and Reusable Patch designs, Tubing is evaluated across PVC and Silicone constructions, and Wearable devices are differentiated between Non-Smart Wearable and Smart Wearable offerings. Patch pumps and wearable systems have emerged as important enablers of ambulatory and home-based therapy, with smart wearables adding telemetric capabilities and adherence analytics. Tubing material choices affect chemical compatibility, kinking resistance, and sterilization pathways and therefore influence clinical preference and supply chain planning.

Based on Application, the focus spans Anesthesia, Infusion, and Pain Management. Application-specific requirements influence dosing precision, programmability, and alarm logic. Anesthesia contexts demand rapid response and seamless integration with perioperative workflows, infusion contexts emphasize long-duration accuracy and compatibility with various therapeutic agents, and pain management applications prioritize patient comfort, simplified user controls, and adherence monitoring to prevent misuse. Integrating these segmentation lenses reveals where incremental innovation will yield the greatest operational and clinical returns and where commercialization strategies can be aligned with end-user pain points.

Regional adoption patterns and strategic implications across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping commercialization and product configuration decisions

Regional dynamics shape adoption pathways, regulatory expectations, and supply chain configurations for patient delivery systems, and leaders must interpret regional signals to align product design and market entry strategies. In the Americas, health systems are intensifying investments in digital integration and post-market evidence collection; as a consequence, devices that offer connectivity, data analytics, and clear clinical performance metrics are increasingly favored. This region also shows pronounced interest in solutions that support outpatient and home-based therapy due to demographic trends and cost containment pressures.

In Europe, the Middle East & Africa, regulatory heterogeneity and varying levels of healthcare infrastructure create a mosaic of adoption conditions. Reimbursement frameworks and centralized procurement in parts of Europe encourage rigorous clinical evidence and lifecycle cost justification, while emerging markets in the Middle East & Africa often prioritize durability, ease of maintenance, and supply-chain robustness. Manufacturers seeking traction in this broad region must balance localized regulatory strategies with product configurations that are adaptable to disparate clinical practice patterns.

In the Asia-Pacific region, rapid capacity expansion, growing domestic manufacturing capability, and an expanding ambulatory care footprint are driving demand for scalable, cost-efficient delivery systems. Local players in several countries have advanced capabilities in component manufacturing and assembly, which creates competitive dynamics that favor cost-effective innovation and rapid iteration. Cross-border partnerships and regional distribution networks are therefore critical for companies aiming to scale, and alignment with local clinical workflows and language localization for user interfaces is a recurring success factor.

Across all regions, differences in sterilization infrastructure, clinical workforce training capacity, and procurement governance will continue to determine how quickly new device classes are adopted. Successful market strategies will pair regional regulatory navigation with targeted investments in training, service networks, and evidence generation tailored to the specific expectations of healthcare purchasers in each geography.

Competitive and partnership dynamics among device makers and technology specialists highlighting connectivity, service excellence, and strategic acquisitions driving differentiation

Competitive dynamics among leading device manufacturers and technology providers reveal convergent priorities around connectivity, user-centered design, and evidence generation. Companies that combine robust engineering with comprehensive post-sale service capabilities command greater trust among large health system purchasers who view serviceability and vendor responsiveness as critical components of total device performance. In addition, manufacturers that have invested early in secure connectivity and cloud-based analytics have a competitive advantage in demonstrating longitudinal device performance and adherence metrics that clinicians increasingly require.

Strategic partnerships and selective acquisitions are common tactics as firms seek to augment software capabilities, telemedicine integration, and advanced sensor portfolios. These moves enable faster entry into emerging product categories such as smart wearables and patch pumps while leveraging established distribution networks to accelerate clinical trials and post-market surveillance efforts. At the same time, some incumbents are responding to new entrants by reimagining their service models to include training-as-a-service and device-as-a-service propositions that can reduce upfront capital barriers for hospitals and clinics.

Newer entrants and smaller specialists that excel in a narrow technological domain-whether in microfluidics, secure embedded software, or novel materials-are influencing product roadmaps across the industry by demonstrating focused clinical benefits and niche adoption pathways. Their agility often forces larger firms to experiment with modular product designs and faster iterative cycles. Overall, success in the competitive landscape requires a balanced strategy that marries product differentiation with operational excellence in manufacturing, regulatory compliance, and after-sales service.

Actionable strategic recommendations for manufacturers and health systems focusing on interoperability, human factors, sterilization protocols, and supply chain resilience

Industry leaders should prioritize interoperability, human factors engineering, and supply chain resilience as immediate levers to sustain competitive advantage and clinical credibility. Embedding standardized connectivity and open APIs into device architectures will ease integration with electronic health records and remote monitoring platforms, which in turn supports clinician adoption and longitudinal evidence collection. Alongside technical integration, focused investment in human factors testing and simplified user interfaces will reduce training overhead and lower the risk of user error in non-specialist settings.

Manufacturers and health systems should co-develop sterilization and reprocessing protocols early in the design cycle to avoid downstream operational friction. Clear, field-validated cleaning procedures and service manuals will accelerate hospital credentialing and enable broader use in clinics and home-care environments. Additionally, firms should evaluate nearshoring options for critical components and build multi-tier supplier redundancy to buffer against tariff-induced cost volatility and geopolitical disruption.

To strengthen market positioning, companies should adopt outcome-oriented evidence strategies that couple clinical trial data with pragmatic real-world performance metrics. Demonstrating improvements in adherence, therapy continuity, and clinical workflow efficiency will resonate with value-conscious purchasers. Finally, leaders should explore flexible commercial models, such as subscription services or bundled training and maintenance packages, to lower adoption barriers and align incentives between manufacturers and care providers.

Transparent, multi-method research methodology combining expert interviews, device technical assessments, and workflow analyses to derive actionable operational insights

The research approach combined qualitative expert interviews, device-level technical assessments, and cross-functional workflow analyses to triangulate insights on technology performance and adoption barriers. Primary research included structured discussions with clinicians, biomedical engineers, procurement leaders, and trained caregivers to surface operational pain points and to validate device usability under realistic clinical scenarios. These engagements were complemented by technical reviews of device specifications, sterilization requirements, and materials compatibility to assess implications for reprocessing and lifecycle management.

Secondary research synthesized regulatory guidance, clinical practice standards, and published evidence on device safety and performance, while ensuring careful vetting of sources and an emphasis on peer-reviewed literature and regulatory documentation. Comparative analysis across product platforms focused on design trade-offs-such as disposability versus reusability, material selection, and integration capability-with attention to how these trade-offs manifest in real-world clinical settings. The methodology prioritized reproducibility and transparency, documenting data sources and analytical assumptions to enable readers to trace how insights were derived and to apply them to their specific organizational contexts.

Closing synthesis emphasizing the imperative of interoperable, human-centered delivery systems supported by evidence and supply chain resilience to realize clinical value

In conclusion, patient delivery systems stand at the intersection of device engineering, clinical workflow design, and health system operational strategy. The convergence of smart technologies, shifting care settings, and heightened regulatory expectations is redefining the attributes that matter most to purchasers: connectivity, ease of use, reprocessing clarity, and demonstrable clinical outcomes. Organizations that align product design with real-world clinical workflows, build resilient supply chains, and substantiate claims with post-market evidence will be best positioned to capture durable adoption across diverse care environments.

Moving forward, collaboration across manufacturers, health systems, and regulators will be essential to realize the full potential of emerging delivery technologies and to ensure patient safety as devices take on more active roles in therapy management. By focusing on interoperable designs, human-centered interfaces, and robust evidence strategies, stakeholders can drive adoption pathways that improve patient outcomes while containing operational complexity and cost.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Over Patient Delivery System Market, by Delivery Mode

  • 8.1. Automated
    • 8.1.1. Bolus
    • 8.1.2. Continuous
    • 8.1.3. Intermittent
  • 8.2. Manual
    • 8.2.1. Gravity
    • 8.2.2. Push

9. Over Patient Delivery System Market, by Product Type

  • 9.1. Disposable
    • 9.1.1. Plastic
    • 9.1.2. Silicone
  • 9.2. Reusable
    • 9.2.1. Autoclavable
    • 9.2.2. Nonautoclavable

10. Over Patient Delivery System Market, by Technology

  • 10.1. Patch Pump
    • 10.1.1. Disposable Patch
    • 10.1.2. Reusable Patch
  • 10.2. Tubing
    • 10.2.1. Pvc
    • 10.2.2. Silicone
  • 10.3. Wearable
    • 10.3.1. Non-Smart Wearable
    • 10.3.2. Smart Wearable

11. Over Patient Delivery System Market, by Application

  • 11.1. Anesthesia
  • 11.2. Infusion
  • 11.3. Pain Management

12. Over Patient Delivery System Market, by End User

  • 12.1. Clinics
  • 12.2. Home Care
    • 12.2.1. Patient Self-Administered
    • 12.2.2. Skilled Nursing
  • 12.3. Hospitals
    • 12.3.1. Emergency
    • 12.3.2. General Ward
    • 12.3.3. Icu

13. Over Patient Delivery System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Over Patient Delivery System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Over Patient Delivery System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Over Patient Delivery System Market

17. China Over Patient Delivery System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Acteon Group
  • 18.6. Anthos s.r.l.
  • 18.7. Being Foshan Medical Equipment Co., Ltd.
  • 18.8. Chirana Holding a.s.
  • 18.9. Cingolani S.r.l.
  • 18.10. Confident Dental Equipment Pvt. Ltd.
  • 18.11. Dentsply Sirona Inc.
  • 18.12. Diplomat Dental s.r.o.
  • 18.13. Flight Dental Systems
  • 18.14. Forest Dental Products, Inc.
  • 18.15. Gnatus International Ltda.
  • 18.16. Hican S.A.
  • 18.17. KaVo Dental GmbH
  • 18.18. Marus Dental International
  • 18.19. Mestra Talleres S.L.
  • 18.20. Midmark Corporation
  • 18.21. Planmeca Oy
  • 18.22. Ritter Concept GmbH
  • 18.23. Stern Weber s.r.l.
  • 18.24. Takara Belmont Corporation
  • 18.25. United Medical Equipment Co., Ltd.
  • 18.26. Yoshida Dental Mfg. Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES OVER PATIENT DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY BOLUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY BOLUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY BOLUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY INTERMITTENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GRAVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GRAVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GRAVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PUSH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PUSH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PUSH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOCLAVABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOCLAVABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOCLAVABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY NONAUTOCLAVABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY NONAUTOCLAVABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY NONAUTOCLAVABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE PATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE PATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE PATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE PATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY NON-SMART WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY NON-SMART WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY NON-SMART WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SMART WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SMART WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SMART WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATIENT SELF-ADMINISTERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATIENT SELF-ADMINISTERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATIENT SELF-ADMINISTERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SKILLED NURSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SKILLED NURSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SKILLED NURSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY EMERGENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY EMERGENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GENERAL WARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GENERAL WARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GENERAL WARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY ICU, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY ICU, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY ICU, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 254. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 255. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 256. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 258. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 259. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 261. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 262. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 263. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 266. GCC OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 297. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 298. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 300. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 301. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DISPOSABLE, 2018-2032 (USD MILLION)
  • TABLE 303. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 304. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 305. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PATCH PUMP, 2018-2032 (USD MILLION)
  • TABLE 306. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 307. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 308. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 311. G7 OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 312. NATO OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 313. NATO OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 314. NATO OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY AUTOMATED, 2018-2032 (USD MILLION)
  • TABLE 315. NATO OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 316. NATO OVER PATIENT DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)